AirSculpt Technologies Q4 Earnings Analysis

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: Apr 03 2026

0mins

AIRS+11.56%

Should l Buy AIRS?

Source: seekingalpha

Disappointing Earnings: AirSculpt Technologies reported a Q4 non-GAAP EPS of -$0.02 with revenues of $33.4 million, reflecting a 14.8% year-over-year decline and missing expectations by $5.5 million, indicating pressure in market competition.
2026 Outlook: The company anticipates 2026 revenues between $151 million and $157 million, slightly below the consensus estimate of $153.5 million, reflecting a cautious stance on future growth, with adjusted EBITDA projected at approximately $15 million to $17 million.
Debt Leverage Target: AirSculpt aims to maintain net debt leverage below 2.5x, a strategic move designed to enhance financial flexibility and reduce risk, supporting future business expansion efforts.
Market Reaction Analysis: Despite the disappointing financial performance, the company's low valuation may present a buying opportunity for investors, highlighting market interest in its long-term potential.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy AIRS?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on AIRS

About AIRS

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

AirSculpt Technologies Q1 2026 Earnings Call Insights

1 day agoseekingalpha

Revenue Stability: AirSculpt reported Q1 2026 revenue of $39.4 million, flat year-over-year and up 1% on a same-store basis, indicating a gradual recovery after a 16% decline, suggesting that the company's market strategies are beginning to yield results.
Financial Health Improvement: The company ended the quarter with over $16 million in cash and reduced leverage to below 2.5x, indicating ongoing financial health improvements that provide greater flexibility for future investments and expansions.
New Service Potential: CEO Jashnani noted that over 150 skin excision procedures were completed in Q1, with new GLP-1-adjacent procedures expected to unlock more than $100 million in long-term revenue potential across existing centers, highlighting the strategic significance of new business lines.
Enhanced Marketing Strategy: CFO Arthur emphasized an increase in marketing investment to approximately $22.6 million, which raised spending by $800,000, yet is aimed at driving sales growth, indicating the company's strategy to enhance customer acquisition efficiency in a competitive market.

AirSculpt Technologies Reports Q1 Earnings and 2026 Guidance

2 days agoseekingalpha

Earnings Performance: AirSculpt Technologies reported a Q1 GAAP EPS of -$0.03, aligning with expectations, indicating stability in profitability amidst market challenges.
Revenue Insights: The company achieved revenue of $39.4 million for the quarter, flat year-over-year, but exceeding market expectations by $0.17 million, reflecting resilience in sales performance.
Future Guidance: AirSculpt affirmed its 2026 revenue guidance of approximately $151 million to $157 million, with adjusted EBITDA projected between $15 million and $17 million, showcasing confidence in future growth prospects.
Financial Health: The company aims to maintain net debt leverage below 2.5x, highlighting a commitment to financial stability while pursuing business expansion.

AirSculpt Reports Solid Q1 Results with Revenue Stabilization

2 days agoNewsfilter

Stable Performance: In Q1 2026, AirSculpt reported a case volume of 3,082, reflecting a slight 0.2% increase from 3,076 in Q1 2025, indicating the company's resilience and sustained market appeal, which bolsters investor confidence.
Flat Revenue: The revenue for the first quarter stood at $39.4 million, unchanged from the same period in 2025, but increased by 1% on a same-center sales basis, demonstrating positive progress in enhancing customer experience and sales strategies.
Reduced Net Loss: The net loss for the quarter was $2.4 million, an improvement from $2.8 million in Q1 2025, reflecting ongoing efforts in cost control and operational efficiency, which enhances expectations for future profitability.
Optimistic Financial Outlook: AirSculpt affirmed its full-year 2026 revenue guidance of approximately $151 to $157 million and adjusted EBITDA guidance of $15 to $17 million, showcasing the company's confidence in future growth and the effectiveness of its strategic planning.

AirSculpt Technologies Updates 2025 Financial Results

Apr 06 2026Newsfilter

Performance Decline: In Q4 2025, case volume dropped to 2,604, a 15.0% decrease from 3,064 in Q4 2024, indicating a weakening customer demand amid intensified market competition, which led to a 14.6% revenue decline to $33.4 million, adversely affecting the company's financial health.
Increased Net Loss: The full-year net loss for 2025 was $11.7 million, up from $8.0 million in 2024, highlighting the challenges the company faces in improving profitability amidst strategic adjustments and changing market conditions, which could undermine investor confidence.
Declining Adjusted EBITDA: Adjusted EBITDA for 2025 was $12.5 million, a 40.5% decrease from $21.0 million in 2024, indicating pressure on cost control and operational efficiency, which may impact future capital investments and expansion plans.
2026 Outlook: The company projects 2026 revenue between $151 million and $157 million, with adjusted EBITDA of $15 million to $17 million; while the outlook appears cautiously optimistic, the actual impact will depend on the pace of market recovery and its effects on the company's finances.